Ongoing Randomized Trials: Where They Stand and What They Stand To Prove or Disprove - Gerald S. Werner, MD, PhD

↳ This is a section part of Moment: CRT 2015 Coronary - Session 1: Like It or Not You Need to Know the Data

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Ongoing Randomized Trials: Where They Stand and What They Stand To Prove or Disprove presented by Gerald S. Werner, MD, PhD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: Session 1: Like It or Not You Need to Know the Data

Track: Coronary

Learning Objectives

  • Update in advances in CTO

Other Components in this Moment

Overview
Histopathologic Insights into Chronically Occluded Coronary Arteries – The Post-CABG vs Unbypassed CTO - Renu Virmani, MD
Native Coronary Patency after CABG Surgery: Clinical Implications - B. Strauss, MD, PhD
The Rationale for CTO PCI: The Latest on Symptom Relief and Survival From Registries and Meta Analyses - Carlo Di Mario, MD
Success and Safety of Contemporary CTO-PCI: The Latest From Recent Registries and Meta Analyses - D. Karmpaliotis , MD, PhD
Ongoing Randomized Trials: Where They Stand and What They Stand To Prove or Disprove - Gerald S. Werner, MD, PhD
The FDA’s View on CTO PCI: Why Everyday Devices Need CTO Specific Indications - Tara A Ryan, MD, MBA
Loading Simple Education